Cerenome Return on Equity (ROE) Growth & History (CNSY)

Cerenome's return on equity was −522.50% for fiscal 2023.

View full Cerenome company overview

Cerenome annual return on equity history

Cerenome annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20232023-12-31−522.50%−287.85 pp
20222022-12-31−234.65%−41.40 pp
20212021-12-31−193.25%+200.02 pp
20202020-12-31−393.27%−52.25 pp
20192019-12-31−341.02%−202.37 pp
20182018-12-31−138.64%+50.52 pp
20172017-12-31−189.16%+0.96 pp
20162016-12-31−190.12%+386.27 pp
20152015-12-31−576.38%
20132013-12-31−546.09%−152.47 pp
20122012-12-31−393.62%−195.86 pp
20112011-12-31−197.76%+88.41 pp
20102010-12-31−286.17%

Cerenome return on equity trends

Over the last five fiscal years, Cerenome's return on equity decreased from −138.64% to −522.50%, a change of −383.86 percentage points. The latest reported quarter, Q2 2026, shows −103.37%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cerenome source filings ↗

Community posts

It’s quiet here.

No posts about CNSY yet. Start the conversation.

Write the first post